Endothelial cell infection and endotheliitis in COVID-19
2020/04/21 by Zsuzsanna Varga, Andreas J. Flammer, Andreas J Flammer +11 · 33 citations
Medicine · #COVID-19 Clinical Research Studies #Inflammatory Biomarkers in Disease Prognosis #Sepsis Diagnosis and Treatment
paper · pdf · doi:10.1016/s0140-6736(20)30937-5
openalex publication_date 2020/04/21 · crossref created 2020/04/21 · crossref issued 2020/05/01 · crossref published 2020/05/01 · crossref published-print 2020/05/01 · crossref deposited 2025/09/26 · openalex created_date 2025/10/10 · crossref indexed 2026/07/30 · openalex updated_date 2026/07/31
Citations
Cited by
- Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19
- Overview and Pathophysiology of Long COVID
- Cardiovascular outcomes in long COVID-19: a systematic review and meta-analysis
- Prevalence of cardiovascular symptoms in post-acute COVID-19 syndrome: a meta-analysis
- Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship
- Unraveling the relevance of SARS-Cov-2 infection and ferroptosis within the heart of COVID-19 patients
- Post-viral effects of COVID-19 in the olfactory system and their implications
- Endothelial dysfunction in COVID-19: Current findings and therapeutic implications
- Vascular “Long COVID”: A New Vessel Disease?
- Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- Efferocytosis of apoptotic bodies drives SARS-CoV-2 infection and macrophage inflammation
- Damage to endothelial barriers and its contribution to long COVID
- Long COVID: pathophysiological factors and abnormalities of coagulation
- COVID-19 in the Initiation and Progression of Atherosclerosis
- COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type
- The blood–brain barrier in systemic infection and inflammation
- Does COVID‐19 cause or worsen LUT dysfunction, what are the mechanisms and possible treatments? ICI‐RS 2023
- The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
- Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study
- Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study
- The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19
- 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play
- Extrapulmonary manifestations of COVID-19
- Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis
- Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
- Complement activation and endothelial perturbation parallel COVID-19 severity and activity
- N-Acetylcysteine in the Treatment of Acute Lung Injury: Perspectives and Limitations
- IL-6 and D-dimer Levels at Admission Predict Cardiac Injury and Early Mortality during SARS-CoV-2 Infection
- Post-acute COVID-19 syndrome
- COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
- COVID-19 and thrombosis: The role of hemodynamics
- Programmed cell death: the pathways to severe COVID-19?